Ganciclovir and Valganciclovir Use Among Infants With Congenital Cytomegalovirus: Data From a Multicenter Electronic Health Record Dataset in the United States

Overview

Journal J Pediatric Infect Dis Soc

Publisher Oxford University Press

Specialties Infectious Diseases
Pediatrics

Date 2022 May 9

PMID 35532552

Authors

Jessica Leung

Scott D Grosse

Bryan Yockey

Tatiana M Lanzieri

Affiliations

Soon will be listed here.

Abstract

Among 342 US infants with congenital cytomegalovirus treated with antivirals, 114 (33%) received ganciclovir (with or without valganciclovir) and 228 (67%) received valganciclovir only, for a median of 8 and 171 days, starting at a median of 15 and 45 days of life, respectively, with neutropenia diagnosed in 25% and 17%.

Citing Articles

Dosing, Toxicity and Drug Concentrations for Ganciclovir/Valganciclovir in Preterm and Low Birthweight Infants Treated for Cytomegalovirus.

Abu Bakar A, Payne H, Tickner N, Muhd Helmi M, Jacobs T, Lyall H Pediatr Infect Dis J. 2025; 44(4):319-325.

PMID: 40063966 PMC: 11888825. DOI: 10.1097/INF.0000000000004605.

Congenital Cytomegalovirus Severity Definitions and Treatment Decisions around the World: A Systematic Scoping Review of the Literature.

Boscarino G, Romano R, Tegoni F, Iotti C, Perrone S, Esposito S J Clin Med. 2024; 13(19).

PMID: 39408057 PMC: 11477784. DOI: 10.3390/jcm13195997.

Ophthalmic Complications, Diagnosis, and Treatment of Congenital Human Cytomegalovirus Infection.

Modrzejewska M, Polubinski P, Zdanowska O J Clin Med. 2024; 13(12).

PMID: 38929909 PMC: 11203846. DOI: 10.3390/jcm13123379.

Hygiene-based measures for the prevention of cytomegalovirus infection in pregnant women: a systematic review.

Rodriguez-Munoz M, Martin-Martin C, Kovacheva K, Olivares M, Izquierdo N, Perez-Romero P BMC Pregnancy Childbirth. 2024; 24(1):172.

PMID: 38424481 PMC: 10905865. DOI: 10.1186/s12884-024-06367-5.

Estimates of congenital cytomegalovirus-attributable infant mortality in high-income countries: A review.

Grosse S, Fleming P, Pesch M, Rawlinson W Rev Med Virol. 2024; 34(1):e2502.

PMID: 38282398 PMC: 10878676. DOI: 10.1002/rmv.2502.